Christopher Schnieders settled a case on behalf of a 35-year-old man with renal impairment against a manufacturer of gadolinium for a confidential amount.
The lawsuit, filed in the U.S. District Court for the Northern District of Ohio, alleged that the defendant manufacturer failed to warn doctors of the toxic nature of gadolinium when used in a patient with impaired kidney function. Gadolinium is a substance commonly used as contrast in MRIs and other body scans. In patients with renal impairment, the contrast takes a prolonged period of time to clear out of the body, leading to the devastating condition known as nephrogenic systemic fibrosis (NSF), a rare and serious syndrome that involves fibrosis of skin, joints, eyes, and internal organs.
Christopher successfully argued that because of the use of gadolinium in this client’s MRI, his client contracted NSF and related injuries including exacerbation of internal organ injuries.